{"SPADE_UN_12178": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 2003/0077289 A1", "Patent Link": "http://www.lens.org/lens/patent/US_2003_0077289_A1", "Patent Type": "Patent Application", "Publication Date": "2003-4-24", "Family Info": "CN1309417C,CN1503628A,WO2002064057A2,WO2002064057A3", "Patent Title": "Use of cell-penetrating peptides to generate antitumor immunity.", "Abstract": "The present invention is directed to methods and compositions for enhancing an immune response in an animal to a disease by administering an immune effector cell comprising a cell penetrating peptide associated with an antigen for the disease. In a specific embodiment, the immune effector cell is a dendritic cell comprising a cell penetrating peptide associated with an antitumor antigen for cancer immunotherapy."}], "Sequence Information": {"SPADE ID": "SPADE_UN_12178", "Peptide Name": "KFGF", "Source": "Synthetic construct", "Family": "Not found", "Gene": "Not found", "Sequence": "AAVLLPVLLAAP", "Sequence Length": 12, "UniProt Entry": "No entry found", "Protein Existence": "Synthetic form", "Biological Activity": ["Antimicrobial", "Antibacterial", "Anti-Gram+", "Anti-Gram-"], "Target Organism": "[Ref.28921993] Gram-positive bacteria:Staphylococcus aureus (MIC > 256 μg/mL), Enterococcus faecalis (MIC > 256 μg/mL);Gram-negative bacteria:Escherichia coli (MIC > 256 μg/mL), Pseudomonas aeruginosa (MIC > 256 μg/mL)", "Hemolytic Activity": "[Ref.28921993] 0.4%, 0.2%, 0.3%, 0.2%, 1.5%, 0.2% and 0.1% hemolysis against human red blood cells at 7.5, 10, 15, 20, 25, 30 and 40 μg/ml.", "Cytotoxicity": "[Ref.28921993] The toxicity of KFGF toward HEK293 and HeLa cells is much less than nonaarginine (R9) by use of flow cytometry and the peptide doesn't show any cytotoxicity at 2 μM.", "Binding Target": "Not found", "Linear/Cyclic": "Linear", "N-terminal Modification": "Free", "C-terminal Modification": "Amidation", "Stereochemistry": "L", "Structure Description": "Our CD data show that all four linear peptides were generally disordered in aqueous solution, as expected, but prominent effects were seen regarding the impact of the staple.", "Formula": "C₅₆H₉₈N₁₂O₁₃", "Mass": 1147.45, "PI": 5.57, "Net Charge": 0, "Hydrophobicity": 2.3, "Half Life": "Mammalian:4.4 hourYeast:>20 hourE.coli:>10 hour", "Function": "Antibacterial activity against Gram-positive and Gram-negative bacteria.", "Literature": [{"Title": "Lactam-Stapled Cell-Penetrating Peptides Cell Uptake and Membrane Binding Properties.", "Pubmed ID": "28921993", "Reference": "J Med Chem. 2017 Oct 12;60(19)8071-8082. doi 10.1021/acs.jmedchem.7b00813. Epub 2017 Sep 26.", "Author": "Marco J Klein, Samuel Schmidt, Parvesh Wadhwani, Jochen Bürck, Johannes Reichert, Sergii Afonin, Marina Berditsch, Tim Schober, Roland Brock, Manfred Kansy, Anne S Ulrich", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=28921993"}], "Frequent Amino Acids": "ALP", "Absent Amino Acids": "CDEFGHIKMNOQRSTUWY", "Basic Residues": 0, "Acidic Residues": 0, "Hydrophobic Residues": 12, "Polar Residues": 6, "Positive Residues": 0, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_14834", "Similarity": 1.0, "Sequence": "HSDGIFTDSYSRYRKQMAVKKYLAAVL"}, {"SPADE_ID": "SPADE_N_10195", "Similarity": 0.8, "Sequence": "LQKYYARVRGGRAAVLS"}, {"SPADE_ID": "SPADE_UN_29158", "Similarity": 0.8, "Sequence": "LQKYYARVRGGRAAVLS"}]}}}